Interleukin-2: a double-edge sword in allogeneic stem cell transplantation

Batia Avni; Sigal Grisariu; Michael Y Shapira

doi:10.2217/imt.15.117

Interleukin-2: a double-edge sword in allogeneic stem cell transplantation

Immunotherapy. 2016;8(3):241-3. doi: 10.2217/imt.15.117. Epub 2016 Feb 9.

Authors

Batia Avni¹, Sigal Grisariu¹, Michael Y Shapira¹

Affiliation

¹ Department of Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

PMID: 26860186
DOI: 10.2217/imt.15.117

No abstract available

Keywords: IL-2; alloimmunity; graft versus host disease; graft versus leukemia effect; immune modulation; immune suppression; immunotherapy; lymphokine-activated killer cells; regulatory T cells; stem cell transplantation.

Publication types

Editorial

MeSH terms

Animals
Drug Therapy, Combination
Graft vs Leukemia Effect / immunology*
Humans
Immunotherapy*
Interferon-gamma / immunology
Interferon-gamma / therapeutic use
Interleukin-2 / immunology*
Interleukin-2 / therapeutic use
Killer Cells, Natural / immunology*
Lymphoma, Non-Hodgkin / immunology
Lymphoma, Non-Hodgkin / therapy*
Stem Cell Transplantation*
T-Lymphocytes / immunology*
Transplantation, Homologous

Substances

Interleukin-2
Interferon-gamma